Published in Am J Nephrol on October 10, 2008
Chronic nicotine exposure augments renal oxidative stress and injury through transcriptional activation of p66shc. Nephrol Dial Transplant (2013) 1.53
Nicotine worsens the severity of nephropathy in diabetic mice: implications for the progression of kidney disease in smokers. Am J Physiol Renal Physiol (2010) 0.95
Nicotine exposure and the progression of chronic kidney disease: role of the α7-nicotinic acetylcholine receptor. Am J Physiol Renal Physiol (2012) 0.88
Vitamin E reversed nicotine-induced toxic effects on bone biochemical markers in male rats. Arch Med Sci (2010) 0.88
Kidney function and tobacco smoke exposure in US adolescents. Pediatrics (2013) 0.84
A review on renal toxicity profile of common abusive drugs. Korean J Physiol Pharmacol (2013) 0.82
Hypoxia: The Force that Drives Chronic Kidney Disease. Clin Med Res (2016) 0.80
Harmful effects of nicotine. Indian J Med Paediatr Oncol (2015) 0.79
Nicotine signaling and progression of chronic kidney disease in smokers. Biochem Pharmacol (2013) 0.78
Genetic variants in nicotinic acetylcholine receptor genes jointly contribute to kidney function in American Indians: the Strong Heart Family Study. J Hypertens (2014) 0.77
Nicotine-Induced Apoptosis in Human Renal Proximal Tubular Epithelial Cells. PLoS One (2016) 0.76
Nicotine Induces Podocyte Apoptosis through Increasing Oxidative Stress. PLoS One (2016) 0.75
Smoking patterns and chronic kidney disease in US Hispanics: Hispanic Community Health Study/Study of Latinos. Nephrol Dial Transplant (2016) 0.75
Smoking-Related Renal Histologic Injury in IgA Nephropathy Patients. Yonsei Med J (2016) 0.75
Design and implementation of the Hispanic Community Health Study/Study of Latinos. Ann Epidemiol (2010) 4.61
Surgical menopause increases salt sensitivity of blood pressure. Hypertension (2006) 2.38
Development of (17)O NMR approach for fast imaging of cerebral metabolic rate of oxygen in rat brain at high field. Proc Natl Acad Sci U S A (2002) 1.85
Prevalence of hypertension, awareness, treatment, and control in the Hispanic Community Health Study/Study of Latinos. Am J Hypertens (2014) 1.83
Concerted nitric oxide formation and release from the simultaneous reactions of nitrite with deoxy- and oxyhemoglobin. J Biol Chem (2007) 1.57
Sodium challenge does not support an acute gastrointestinal-renal natriuretic signaling axis in humans. Kidney Int (2012) 1.46
Stable compounds of cigarette smoke induce endothelial superoxide anion production via NADPH oxidase activation. Arterioscler Thromb Vasc Biol (2004) 1.30
Systemic and Regional Hemodynamic Responses to Tempol in Angiotensin II-Infused Hypertensive Rats. Hypertension (2001) 1.22
Nicotine: the link between cigarette smoking and the progression of renal injury? Am J Physiol Heart Circ Physiol (2006) 1.15
Reduced NAD(P)H oxidase in low renin hypertension: link among angiotensin II, atherogenesis, and blood pressure. Hypertension (2005) 1.13
Up-regulation of glomerular COX-2 by angiotensin II: role of reactive oxygen species. Kidney Int (2005) 1.13
In salt-sensitive hypertension, increased superoxide production is linked to functional upregulation of angiotensin II. Hypertension (2003) 1.12
Postovariectomy hypertension is linked to increased renal AT1 receptor and salt sensitivity. Hypertension (2003) 1.07
Angiotensin receptor blocker/diuretic combination preserves insulin responses in obese hypertensives. J Hypertens (2010) 1.06
Body mass index and hypertension hemodynamic subtypes in the adult US population. Arch Intern Med (2009) 1.04
Upregulation of cortical COX-2 in salt-sensitive hypertension: role of angiotensin II and reactive oxygen species. Am J Physiol Renal Physiol (2007) 1.04
Atorvastatin prevents end-organ injury in salt-sensitive hypertension: role of eNOS and oxidant stress. Hypertension (2004) 1.02
Renoprotection by statins is linked to a decrease in renal oxidative stress, TGF-beta, and fibronectin with concomitant increase in nitric oxide bioavailability. Am J Physiol Renal Physiol (2008) 1.01
Human glomerular endothelium: interplay among glucose, free fatty acids, angiotensin II, and oxidative stress. Am J Physiol Renal Physiol (2009) 1.00
Prevalence and patterns of hypertension in Peruvian Andean Hispanics: the PREVENCION study. J Am Soc Hypertens (2010) 0.95
Nicotine worsens the severity of nephropathy in diabetic mice: implications for the progression of kidney disease in smokers. Am J Physiol Renal Physiol (2010) 0.95
Angiotensin II increases the expression of the transcription factor ETS-1 in mesangial cells. Am J Physiol Renal Physiol (2008) 0.95
Role of angiotensin II in the development of nephropathy and podocytopathy of diabetes. Curr Diabetes Rev (2011) 0.94
Vascular but not cardiac remodeling is associated with superoxide production in angiotensin II hypertension. J Hypertens (2005) 0.94
Nitric oxide, angiotensin II, and reactive oxygen species in hypertension and atherogenesis. Curr Hypertens Rep (2005) 0.93
Interaction between nitric oxide and angiotensin II in the endothelium: role in atherosclerosis and hypertension. J Hypertens Suppl (2006) 0.93
Vascular inflammation, insulin resistance, and endothelial dysfunction in salt-sensitive hypertension: role of nuclear factor kappa B activation. J Hypertens (2010) 0.93
Increased nitrite reductase activity of fetal versus adult ovine hemoglobin. Am J Physiol Heart Circ Physiol (2008) 0.93
Thiazide diuretics, endothelial function, and vascular oxidative stress. J Hypertens (2008) 0.92
Nitric oxide, angiotensin II, and hypertension. Semin Nephrol (2004) 0.92
Interaction of haemodynamic and metabolic pathways in the genesis of diabetic nephropathy. J Hypertens (2005) 0.91
Role of angiotensin II and oxidative stress in vascular insulin resistance linked to hypertension. Am J Physiol Heart Circ Physiol (2009) 0.91
Major and minor electrocardiographic abnormalities and their association with underlying cardiovascular disease and risk factors in Hispanics/Latinos (from the Hispanic Community Health Study/Study of Latinos). Am J Cardiol (2013) 0.90
GLUT-1 overexpression: Link between hemodynamic and metabolic factors in glomerular injury? Hypertension (2003) 0.89
The angiotensin II type 2 receptor: what is its clinical significance? Curr Hypertens Rep (2008) 0.87
Metabolic syndrome and endothelial dysfunction. Curr Hypertens Rep (2005) 0.86
Cross-talk between angiotensin II receptor types 1 and 2: potential role in vascular remodeling in humans. Hypertension (2006) 0.86
Inhibition of oxidative stress and improvement of endothelial function by amlodipine in angiotensin II-infused rats. Am J Hypertens (2004) 0.86
Role of c-Jun N-terminal kinase in the regulation of vascular tone. J Cardiovasc Pharmacol Ther (2010) 0.86
Dissociation between metabolic and vascular insulin resistance in aging. Am J Physiol Heart Circ Physiol (2007) 0.86
Nicotine potentiates proatherogenic effects of oxLDL by stimulating and upregulating macrophage CD36 signaling. Am J Physiol Heart Circ Physiol (2013) 0.85
Altered renal expression of angiotensin II receptors, renin receptor, and ACE-2 precede the development of renal fibrosis in aging rats. Am J Nephrol (2010) 0.85
The pharmacokinetics and hemodynamics of sildenafil citrate in male hemodialysis patients. Kidney Int (2004) 0.85
Cross-talk between nitric oxide and endothelium-derived hyperpolarizing factor: synergistic interaction? J Hypertens (2003) 0.85
Calcium channel blockers, endothelial dysfunction, and combination therapy. Aging Clin Exp Res (2005) 0.84
Salt sensitivity and hypertension after menopause: role of nitric oxide and angiotensin II. Am J Nephrol (2006) 0.82
Benazepril combined with either amlodipine or hydrochlorothiazide is more effective than monotherapy for blood pressure control and prevention of end-organ injury in hypertensive Dahl rats. J Cardiovasc Pharmacol (2006) 0.82
Potassium in hypertension and cardiovascular disease. Semin Nephrol (2013) 0.78
Kinetic analysis of DAF-FM activation by NO: toward calibration of a NO-sensitive fluorescent dye. Nitric Oxide (2012) 0.78
Renal protection: are all antihypertensive drugs comparable? Curr Hypertens Rep (2007) 0.77
Combination therapy of amlodipine and atorvastatin has more beneficial vascular effects than monotherapy in salt-sensitive hypertension. Am J Hypertens (2014) 0.76
Agmatine induced NO dependent rat mesenteric artery relaxation and its impairment in salt-sensitive hypertension. Nitric Oxide (2013) 0.76
Glutathiyl radical as an intermediate in glutathione nitrosation. Free Radic Biol Med (2012) 0.76
Nitric oxide synthase and hypertension. Curr Opin Nephrol Hypertens (2002) 0.75
The link between Glut-1 and hypertension in diabetic nephropathy. Curr Hypertens Rep (2006) 0.75